Association Between Dual Diagnosis and Drug-Related Problems in Workplace in Egypt: A Case-Control Study

Abstract

The purpose of this study was to estimate the prevalence of psychiatric and personality disorders among industrial workers with substance use disorders and to investigate the association between this comorbidity and drug-related problems. A total of 353 industrial workers were included in the study. Sociodemographic and clinical data were collected from participants. Compared to controls, workers with substance use disorders were about 19 and 8 times more likely to have psychiatric and personality disorders, respectively. Anxiety (35.4%) and mood disorders (29.2%) were the most common psychiatric disorders among substance use workers. The most common personality disorders among substance use workers included antisocial and borderline (24.6% and 16.9%, respectively). There was a significant association between drug-related problems/dependence and psychiatric (χ2 = 14.04; p < 0.001) and personality disorders (χ2 = 18.74; p < 0.001). Psychiatric and personality disorders are common among substance use workers and are associated with drug-related problems.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Ahmad, B., Mufti, K. A., & Farooq, S. (2001). Psychiatric comorbidity in substance abuse (Opioids). JPMA, 51, 183–190.

    CAS  Google Scholar 

  2. Bassiony, M. M., Salah El-Deen, G. M., Yousef, U., Raya, Y., Abdel-Ghani, M. M., El-Gohari, H., & Atwa, S. A. (2015). Adolescent tramadol use and abuse in Egypt. The American Journal of Drug and Alcohol Abuse, 41(3), 206–211. https://doi.org/10.3109/00952990.2015.1014959.

    Article  PubMed  Google Scholar 

  3. Bassiony, M. M., Youssef, U. M., Hussein, R. A., & Saeed, M. (2016). Psychiatric comorbidity among Egyptian patients with opioid use disorders attributed to tramadol. Journal of Addiction Medicine, 10, 262–268.

    CAS  Article  Google Scholar 

  4. Bassiony, M. M., Abdelghani, M., Salah El-Deen, G. M., Hassan, M. S., El-Gohari, H., & Youssef, U. M. (2018). Opioid use disorders attributed to tramadol among Egyptian university students. Journal of Addiction Medicine, 12(2), 150–155. https://doi.org/10.1097/ADM.0000000000000380.

    Article  PubMed  Google Scholar 

  5. Bassiony, M. M., Fawzy, M., Negm, M., Ibrahim, E., Ibrahim, D., Mokhtar, D., Abdallah, A., & Saad, A. (2019). Substance use disorders among industry workers in Egypt. Addictive Disorders and Their Treatment. https://doi.org/10.1097/ADT.0000000000000162.

  6. Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the drug use disorders identification test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11, 22–31.

    Article  Google Scholar 

  7. Bush, D. M., & Lipari, R. N. (2015). The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US).

    Google Scholar 

  8. Dean, A. G., Arner, T. G., Sunki, G. G., Friedman, R., Lantinga, M., Sangam, S., Zubieta, J. C., Sullivan, K. M., Brendel, K. A., Gao, Z., Fontaine, N., Shu, M., Fuller, G., Smith, D. C., Nitschke, D. A., & Fagan, R. F. (2011). Epi Info™, a database and statistics program for public health professionals. Atlanta: CDC.

    Google Scholar 

  9. Demetrovics, Z. (2009). Co-morbidity of drug addiction: an analysis of epidemiological data and possible etiological models. Addiction Research and Theory, 17(4), 420–431. https://doi.org/10.1080/16066350802601324.

    Article  Google Scholar 

  10. Fawzi, M. M. (2010). Some medicolegal aspects concerning tramadol abuse: the new Middle East youth plague: an Egyptian overview. Egyptian Journal of Forensic Sciences, 1, 99–102.

    Article  Google Scholar 

  11. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1996). Structured clinical interview for DSM-IV axis I disorders, clinician version (SCIDCV). Washington, DC: American Psychiatric Press.

  12. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (1997). Structured clinical interview for DSM-IV—clinical version (SCID-CV) (User's Guide and Interview). Washington, D.C.: American Psychiatric Press, Inc.

    Google Scholar 

  13. Glassman, A. H. (1993). Cigarette smoking: implications for psychiatric illness. The American Journal of Psychiatry, 150(4), 546–553.

    CAS  Article  Google Scholar 

  14. Goplerud, E., Hodge, S., & Benham, T. (2017). A substance use cost calculator for US employers with an emphasis on prescription pain medication misuse. Journal of Occupational and Environmental Medicine, 59(11), 1063–1071. Published online 2017 Sep 20.. https://doi.org/10.1097/JOM.0000000000001157.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., & Hasin, D. S. (2015). Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry, 72(8), 757–766. https://doi.org/10.1001/jamapsychiatry.2015.0584.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  16. Kessler, R. C. (2012). The costs of depression. Psychiatric Clinics of North America, 35(1), 1–14. https://doi.org/10.1111/j.17470285.2012.01428.x.

    Article  Google Scholar 

  17. Kessler, R. C., Nelson, C. R., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: implications for prevention and services utilization. The American Journal of Orthopedics, 66, 17–31.

    CAS  Google Scholar 

  18. Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry, 142(11), 1259–1264.

    CAS  Article  Google Scholar 

  19. Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244.

    CAS  Article  Google Scholar 

  20. Kraemer, H. C., Stice, E., Kazdin, A., Offord, D., & Kupfer, D. (2001). How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry, 158(6), 848–856. https://doi.org/10.1176/appi.ajp.158.6.848.

    CAS  Article  Google Scholar 

  21. Kutlu, M. G., & Gould, T. J. (2015). Nicotine modulation of fear memories and anxiety: implications for learning and anxiety disorders. Biochemical Pharmacology, 97, 498–511.

    CAS  Article  Google Scholar 

  22. Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13. https://doi.org/10.1016/j.drugalcdep.2015.05.031.

    Article  PubMed  Google Scholar 

  23. Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: a population-based prevalence study. JAMA, 284(20), 2606–2610.

    CAS  Article  Google Scholar 

  24. McLellan, A. T., Luborsky, L., Woody, G. E., & O’Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index. The Journal of Nervous and Mental Disease, 168, 26–33.

    CAS  Article  Google Scholar 

  25. Merikangas, K. R., & Mcclair, V. L. (2012). Epidemiology of substance use disorders. Human Genetics, 131(6), 779–789. https://doi.org/10.1007/s00439-012-1168-0.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Mohamed, R. N., Hammad, S. A., EL Hamrawy, L. G., Rajab, A. Z., El Bahy, M. S., Soltan, M. R. (2013). Dual diagnosis and psychosocial correlates in substance abuse in Menoufia, Egypt, Menoufia Medical Journal, 26, 114–121.

    Article  Google Scholar 

  27. Mojtabai, R., Olfson, M., & Mechanic, D. (2002). Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Archives of General Psychiatry, 59, 77–84. https://doi.org/10.1001/archpsyc.59.1.77.

    Article  PubMed  Google Scholar 

  28. Prior, K., Mills, K., Ross, J., & Teesson, M. (2017). Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. Drug and Alcohol Review, 36(3), 317–324. https://doi.org/10.1111/dar.12419.

    Article  PubMed  Google Scholar 

  29. Roche, A. M., Fischer, J., Pidd, K., Lee, N., Battams, S., & Nicholas, R. (2012). Workplace mental illness and substance use disorders in male-dominated industries: a systematic literature review. In National Centre for Education and Training on Addiction (NCETA) report. Australia: Flinders University.

    Google Scholar 

  30. Sareen, J., Chartier, M., Kjernisted, K. D., & Stein, M. B. (2001). Comorbidity of phobic disorders with alcoholism in a Canadian community sample. Canadian Journal of Psychiatry, 46, 733–740.

    CAS  Article  Google Scholar 

  31. Sareen, J., Chartier, M., Paulus, M. P., & Stein, M. B. (2006). Illicit drug use and anxiety disorders: findings from two community surveys. Psychiatry Research, 142(1), 11–17. https://doi.org/10.1016/j.psychres.2006.01.009.

    Article  PubMed  Google Scholar 

  32. Slyepchenko, A., Brunoni, A. R., McIntyre, R. S., Quevedo, J., & Carvalho, A. F. (2016). The adverse effects of smoking on health outcomes in bipolar disorder: a review and synthesis of biological mechanisms. Current Molecular Medicine, 16, 187–205.

    CAS  Article  Google Scholar 

  33. Spitzer, R. L., Williams, J. B. W., Gibbon, M., & First, M. B. (2009). Structured clinical interviews for DSM-IIIR-Patient Addiction (SCID-P) 1990. Washington, DC: American Psychiatric Press. SPSS Inc Released 2009. PASW Statistics for Windows, Version 18.0. Chicago: SPSS Inc.

  34. SPSS Inc Released 2009. PASW Statistics for Windows, Version 18.0. Chicago: SPSS Inc.

  35. Trull, T. J., Jahng, S., Tomko, R. L., Wood, P. K., & Sher, K. J. (2010). Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. Journal of Personality Disorders, 24(4), 412–426. https://doi.org/10.1521/pedi.2010.24.4.412

    Article  PubMed  PubMed Central  Google Scholar 

  36. U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Drugs in the workplace: what an employer needs to know, Available at: http://workplace.samhsa.gov/DrugTesting/Files_Drug_Testing/FactSheet/factsheet041906.aspx. Accessed November 10th, 2018.

  37. U.S. Food & Drug Administration (FDA) (2018) Drugs of abuse home use test. https://www.fda.gov/medical-devices/drugs-abuse-tests/drugs-abuse-home-use-test accessed 16th October 2019.

  38. Walley, A. Y., Paasche-Orlow, M., Lee, E. C., Forsythe, S., Chetty, V. K., Mitchell, S., & Jack, B. W. (2012). Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. Journal of Addiction Medicine, 6(1), 50–56.

    Article  Google Scholar 

  39. Zhou, H., Polimanti, R., Yang, B. Z., Wang, Q., Han, S., Sherva, R., Nuñez, Y. Z., Zhao, H., Farrer, L. A., Kranzler, H. R., & Gelernter, J. (2017). Genetic risk variants associated with comorbid alcohol dependence and major depression. JAMA Psychiatry, 74(12), 1234–1241. https://doi.org/10.1001/jamapsychiatry.2017.3275.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., Calhoun, P. S., & Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10(12), 1691–1715. https://doi.org/10.1080/14622200802443569.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Medhat M. Bassiony.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bassiony, M.M., Ibrahim, E.F. & Youssef, U.M. Association Between Dual Diagnosis and Drug-Related Problems in Workplace in Egypt: A Case-Control Study. Int J Ment Health Addiction 19, 240–251 (2021). https://doi.org/10.1007/s11469-019-00170-6

Download citation

Keywords

  • Substance abuse
  • Industrial workers
  • Egypt